Prenetics Global Limited Class A Ordinary Share (PRE) Stock Price, Quote & News

Company Profile

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into h...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 852 2210 9588

Website: www.prenetics.com

Address:

Unit 703-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong

GranularGlow Dec. 27 at 5:55 PM

$PRE Short‑term swings mask the deeper question: can discipline hold; pipeline visibility needs clearer corroboration — a credible cadence of milestones would shift sentiment. Only demonstrated reliability will sustain upside potential.

0 · Reply

CartographerC Dec. 25 at 11:23 AM

$PRE Market behavior suggests investors are rewarding credible delivery more than theoretical upside. Progress needs to be observable in both leading indicators and reported metrics. Sharper prioritization may be required to avoid execution dilution. Future re‑rating depends on tightening the gap between narrative and reality.

0 · Reply

DARKP00L Dec. 23 at 2:34 PM

$PRE 09:11 on Dec. 23 2025 Prenetics Launches Voluntary Warrant Exchange Program, Representing ~83.4% Of Outstanding Class A and B Warrants; Aims To Simplify Capital Structure, Reduce Potential Dilution By Up To 50%, Consolidate Legacy Warrants Into Single Class C Warrants #tradeideas

0 · Reply

DARKP00L Dec. 23 at 2:25 PM

0 · Reply

SuperGreenToday Dec. 18 at 12:13 AM

$PRE Share Price: $15.93 Contract Selected: Nov 20, 2026 $10 Calls Buy Zone: $2.55 – $3.15 Target Zone: $4.85 – $5.93 Potential Upside: 80% ROI Time to Expiration: 337 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Sidoti Dec. 10 at 6:39 PM

The Prenetics Global Limited ($PRE) Management Team presented today at the Sidoti Year End Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_xAJmgJ0VSxK5S1eK2bMNHQ

1 · Reply

merlin8121 Nov. 20 at 8:28 PM

$PRE https://www.merlintrader.com/top-10-healthcare-small-caps-stocks/

0 · Reply

DARKP00L Nov. 4 at 1:33 PM

$PRE 08:06 on Nov. 04 2025 Prenetics Global Limited Announces Its IM8 Health And Longevity Brand Achieved A Record $108M In Annualized Recurring Revenue In October #tradeideas

0 · Reply

MahiMe Nov. 4 at 1:10 PM

$PRE $PRE Prenetics’ IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch https://www.stocktitan.net/news/PRE/prenetics-im8-achieves-record-9-million-in-revenue-for-october-gbhmu4cglnz6.html

0 · Reply

AStrokeOfLuck Oct. 31 at 2:04 PM

$PRE

0 · Reply

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Nov 25, 2025, 8:49 AM EST - 4 weeks ago

Prenetics Announces Upcoming Conference Participation

Nov 24, 2025, 7:30 AM EST - 4 weeks ago

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Nov 14, 2025, 8:35 AM EST - 6 weeks ago

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Nov 10, 2025, 7:24 AM EST - 6 weeks ago

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

EXOD

Nov 4, 2025, 8:00 AM EST - 7 weeks ago

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

Oct 31, 2025, 8:31 AM EDT - 2 months ago

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

Oct 29, 2025, 4:05 PM EDT - 2 months ago

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Oct 28, 2025, 2:20 PM EDT - 2 months ago

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 27, 2025, 10:12 AM EDT - 2 months ago

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 9, 2025, 12:58 AM EDT - 2 months ago

Prenetics: A Cautious Buy Based On Strong Sales Growth

Oct 8, 2025, 8:04 AM EDT - 2 months ago

Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

Sep 30, 2025, 8:00 AM EDT - 3 months ago

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

Sep 12, 2025, 8:30 AM EDT - 3 months ago

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End

Jun 26, 2025, 4:30 AM EDT - 6 months ago

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Jun 18, 2025, 8:45 AM EDT - 6 months ago

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

Jun 18, 2025, 7:50 AM EDT - 6 months ago

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

Mar 18, 2025, 8:30 AM EDT - 10 months ago

Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Mar 5, 2025, 8:30 AM EST - 10 months ago

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Feb 11, 2025, 8:30 AM EST - 11 months ago

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve

Jan 15, 2025, 8:30 AM EST - 1 year ago

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Dec 5, 2024, 8:30 AM EST - 1 year ago

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Dec 4, 2024, 4:05 PM EST - 1 year ago

Prenetics Announces Participation in December Investor Conferences

Nov 27, 2024, 8:30 AM EST - 1 year ago

Prenetics Announces Third Quarter 2024 Financial Results

Nov 18, 2024, 6:57 AM EST - 1 year ago

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:00 AM EST - 1 year ago

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Aug 19, 2024, 8:30 AM EDT - 1 year ago

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Jul 11, 2024, 8:30 AM EDT - 1 year ago

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Jul 1, 2024, 8:30 AM EDT - 1 year ago

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Jun 18, 2024, 8:30 AM EDT - 1 year ago

Prenetics Announces First Quarter 2024 Financial Results

Apr 1, 2024, 7:30 AM EDT - 1 year ago

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 9, 2024, 9:25 AM EST - 2 years ago

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Nov 20, 2023, 6:00 AM EST - 2 years ago

Prenetics Announces Third Quarter 2023 Financial Results

Nov 1, 2023, 6:00 AM EDT - 2 years ago

Prenetics Global Limited Announces Reverse Stock Split

Sep 15, 2023, 6:58 AM EDT - 2 years ago

Prenetics Announces Second Quarter 2023 Financial Results

Jun 26, 2023, 2:18 AM EDT - 2 years ago

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Jun 25, 2023, 8:45 PM EDT - 2 years ago

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Jun 5, 2023, 7:00 AM EDT - 2 years ago

Prenetics Announces First Quarter 2023 Financial Results

Mar 14, 2023, 8:49 AM EDT - 3 years ago

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 2, 2023, 7:00 AM EST - 3 years ago

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Feb 2, 2023, 4:01 PM EST - 3 years ago

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 19, 2023, 5:00 AM EST - 3 years ago

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

Jan 10, 2023, 8:30 AM EST - 3 years ago

Prenetics Global's stock rallies 82%

Jan 10, 2023, 6:00 AM EST - 3 years ago

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Dec 16, 2022, 6:27 AM EST - 3 years ago

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Nov 30, 2022, 9:15 AM EST - 3 years ago

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

Nov 10, 2022, 8:00 AM EST - 3 years ago

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance

Sep 9, 2022, 9:02 AM EDT - 3 years ago

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Jun 6, 2022, 6:45 AM EDT - 3 years ago

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”

GranularGlow Dec. 27 at 5:55 PM

0 · Reply

CartographerC Dec. 25 at 11:23 AM

0 · Reply

DARKP00L Dec. 23 at 2:34 PM

0 · Reply

DARKP00L Dec. 23 at 2:25 PM

0 · Reply

SuperGreenToday Dec. 18 at 12:13 AM

0 · Reply

Sidoti Dec. 10 at 6:39 PM

The Prenetics Global Limited ($PRE) Management Team presented today at the Sidoti Year End Virtual Conference. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_xAJmgJ0VSxK5S1eK2bMNHQ

1 · Reply

merlin8121 Nov. 20 at 8:28 PM

$PRE https://www.merlintrader.com/top-10-healthcare-small-caps-stocks/

0 · Reply

DARKP00L Nov. 4 at 1:33 PM

$PRE 08:06 on Nov. 04 2025 Prenetics Global Limited Announces Its IM8 Health And Longevity Brand Achieved A Record $108M In Annualized Recurring Revenue In October #tradeideas

0 · Reply

MahiMe Nov. 4 at 1:10 PM

0 · Reply

AStrokeOfLuck Oct. 31 at 2:04 PM

$PRE

0 · Reply

Nova_Trades Oct. 31 at 1:21 PM

$PRE Prenetics adds 100 Bitcoin to its treasury, strengthening its crypto position. Meanwhile, IM8 hits a major milestone — $100M in annual recurring revenue.

0 · Reply

Stock_Catcher Oct. 31 at 12:32 PM

$PRE Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

0 · Reply

DrLohengrin123 Oct. 29 at 7:21 PM

$PRE Looking good

0 · Reply

anachartanalyst Oct. 29 at 4:02 PM

$PRE https://anachart.com/wp-content/uploads/ana_temp/1761753753_soc-img.jpg

0 · Reply

DARKP00L Oct. 29 at 3:03 PM

$PRE 10:24 on Oct. 29 2025 Cantor Fitzgerald Maintains Overweight on Prenetics Global, Raises Price Target to $32 #tradeideas

0 · Reply

DARKP00L Oct. 29 at 2:45 PM

$PRE 10:24 on Oct. 29 2025 Cantor Fitzgerald Maintains Overweight on Prenetics Global, Raises Price Target to $32 #tradeideas

0 · Reply

stoneblood Oct. 28 at 6:23 PM

$PRE $44 million offering just closed will she pump??

0 · Reply

ZippedCookie Oct. 27 at 8:43 PM

@ACInvestorBlog $PRE looks like mega discount today IMO. Am I missing something? I warrants announced are significantly higher than current SP and they are expecting to be profitable in Q1 2026

0 · Reply

NVDAMillionaire Oct. 27 at 7:34 PM

$PRE Brilliant piece that captures PRE's situation perfectly. So if you want to update your understanding of PRE or get to know PRE better, this is essential reading. https://beyondspx.com/quote/PRE/analysis/prenetics-a-biotech-reimagining-health-and-wealth-with-ai-driven-growth-and-a-bitcoin-treasury-nasdaq-pre

0 · Reply

ZippedCookie Oct. 27 at 4:11 PM

$PRE ALL WARRNATS INCLUDED IN OFFERING ARE SIGNIFICANTLY HUGHER THAN CURRENT PRICE.

0 · Reply

topstockalerts Oct. 27 at 3:58 PM

Prenetics Global Ltd shares fell Monday after the health sciences company announced a $48 million public offering. The deal includes nearly 3 million Class A ordinary shares along with an equal number of Class A and Class B warrants. The combined offering price was set at $16.08 per share or pre-funded unit. Class A warrants are exercisable at $24.12 per share (50% premium), and Class B warrants at $32.16 (100% premium), both exercisable immediately for five years. Proceeds will fund global expansion of the IM8 product line and strategic Bitcoin accumulation as part of a “health and wealth” strategy. Dominari Securities acted as sole placement agent; the offering is expected to close October 28, 2025. The sharp share drop suggests investor concern over potential dilution despite growth plans. $PRE

0 · Reply

DARKP00L Oct. 27 at 3:23 PM

$PRE 11:00 on Oct. 27 2025 Prenetics Global shares are trading lower after the company announced a $48 million best efforts public offering. #tradeideas

0 · Reply

Market Cap	284.56M
Revenue (ttm)	30.62M
Net Income (ttm)	-46.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-151.21%
Debt to Equity Ratio	0.00

Volume	49,100
Avg Vol	165,470
Day's Range	N/A - N/A
Shares Out	16.83M
Stochastic %K	65%
Beta	0.35
Analysts	Sell
Price Target	$31.00